107 related articles for article (PubMed ID: 19285818)
1. Concept of a selective tumour therapy and its evaluation by near-infrared fluorescence imaging and flat-panel volume computed tomography in mice.
Alves F; Dullin C; Napp J; Missbach-Guentner J; Jannasch K; Mathejczyk J; Pardo LA; Stühmer W; Tietze LF
Eur J Radiol; 2009 May; 70(2):286-93. PubMed ID: 19285818
[TBL] [Abstract][Full Text] [Related]
2. Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography.
Dullin C; Zientkowska M; Napp J; Missbach-Guentner J; Krell HW; Müller F; Grabbe E; Tietze LF; Alves F
Mol Imaging; 2009; 8(1):2-14. PubMed ID: 19344571
[TBL] [Abstract][Full Text] [Related]
3. Time-domain in vivo near infrared fluorescence imaging for evaluation of matriptase as a potential target for the development of novel, inhibitor-based tumor therapies.
Napp J; Dullin C; Müller F; Uhland K; Petri JB; van de Locht A; Steinmetzer T; Alves F
Int J Cancer; 2010 Oct; 127(8):1958-74. PubMed ID: 20473895
[TBL] [Abstract][Full Text] [Related]
4. How to assess anti-tumour efficacy by imaging techniques.
Gwyther SJ; Schwartz LH
Eur J Cancer; 2008 Jan; 44(1):39-45. PubMed ID: 18060765
[TBL] [Abstract][Full Text] [Related]
5. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice.
Klohs J; Steinbrink J; Bourayou R; Mueller S; Cordell R; Licha K; Schirner M; Dirnagl U; Lindauer U; Wunder A
J Neurosci Methods; 2009 May; 180(1):126-32. PubMed ID: 19427539
[TBL] [Abstract][Full Text] [Related]
7. Engineered affinity proteins for tumour-targeting applications.
Friedman M; Ståhl S
Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363
[TBL] [Abstract][Full Text] [Related]
8. In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia.
Klohs J; Baeva N; Steinbrink J; Bourayou R; Boettcher C; Royl G; Megow D; Dirnagl U; Priller J; Wunder A
J Cereb Blood Flow Metab; 2009 Jul; 29(7):1284-92. PubMed ID: 19417756
[TBL] [Abstract][Full Text] [Related]
9. Imaging the immune response to monitor tumor immunotherapy.
Wang Q; Ornstein M; Kaufman HL
Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
[TBL] [Abstract][Full Text] [Related]
10. Tumour-homing peptides: tools for targeting, imaging and destruction.
Enbäck J; Laakkonen P
Biochem Soc Trans; 2007 Aug; 35(Pt 4):780-3. PubMed ID: 17635147
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive quantitative tomography of the therapeutic response to dexamethasone in ovalbumin-induced murine asthma.
Korideck H; Peterson JD
J Pharmacol Exp Ther; 2009 Jun; 329(3):882-9. PubMed ID: 19293392
[TBL] [Abstract][Full Text] [Related]
12. Molecular PET/CT imaging-guided radiation therapy treatment planning.
Zaidi H; Vees H; Wissmeyer M
Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
[TBL] [Abstract][Full Text] [Related]
13. Response to treatment series: part 2, tumor response assessment--using new and conventional criteria.
Yaghmai V; Miller FH; Rezai P; Benson AB; Salem R
AJR Am J Roentgenol; 2011 Jul; 197(1):18-27. PubMed ID: 21701006
[TBL] [Abstract][Full Text] [Related]
14. Molecular MR imaging and MR-guided ultrasound therapies in cancer.
Grenier N; Quesson B; de Senneville BD; Trillaud H; Couillaud F; Moonen C
JBR-BTR; 2009; 92(1):8-12. PubMed ID: 19358479
[TBL] [Abstract][Full Text] [Related]
15. Trends in veterinary cancer imaging.
Wisner ER; Pollard RE
Vet Comp Oncol; 2004 Jun; 2(2):49-74. PubMed ID: 19379186
[TBL] [Abstract][Full Text] [Related]
16. Imaging tumour-bearing animals using clinical scanners.
Wolf G; Abolmaali N
Int J Radiat Biol; 2009 Sep; 85(9):752-62. PubMed ID: 19479601
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
[TBL] [Abstract][Full Text] [Related]
18. The evolving role of PET-CT in the management of esophageal cancer.
Chuang HH; Macapinlac HA
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):201-9. PubMed ID: 19293768
[TBL] [Abstract][Full Text] [Related]
19. Multimodality molecular imaging.
Tian J; Bai J; Yan XP; Bao S; Li Y; Liang W; Yang X
IEEE Eng Med Biol Mag; 2008; 27(5):48-57. PubMed ID: 18799390
[No Abstract] [Full Text] [Related]
20. Integrated PET/CT and cancer imaging.
De Wever W; Coolen J; Verschakelen JA
JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
